News J.P. Morgan Healthcare Conference Special: Dealmaker of the Year 2024 (Part 01)ByPrince GiriJanuary 8, 20250Comments
News Biocytogen Partners with Acepodia to Develop Bispecific Antibody and Dual-Payload ADCs to Treat Complex TumorsBySenior EditorJanuary 8, 20250Comments
News Avenzo Therapeutics Join Forces with DualityBio to Develop AVZO-1418 (DB-1418) for Solid TumorsBySenior EditorJanuary 8, 20250Comments
News Simpson Interventions Receives the US FDA’s 510(k) Clearance for its Shadow Catheter and IDE Approval for its Acolyte Catheter SystemBySenior EditorJanuary 8, 20250Comments
News Fresenius Kabi Canada Receives Health Canada NOC for Otulfi (Biosimilar, Stelara)ByDipanshu DixitJanuary 8, 20250Comments
News Alloy Therapeutics Partners with Sanofi to Advance Innovative Therapeutics in the CNS SpaceBySenior EditorJanuary 8, 20250Comments
News PharmaEssentia Reports Topline Data from P-III (SURPASS-ET) Trial of Ropeginterferon Alfa-2b-Njft (P1101) in Essential Thrombocythemia (ET)BySenior EditorJanuary 8, 20250Comments
News Orna Collaborates with Vertex to Develop Gene Therapies for Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)BySenior EditorJanuary 8, 20250Comments
INSIGHTS+ J.P. Morgan Healthcare Conference Special: Dealmaker of the Year 2024 (Part 01)ByPrince GiriJanuary 8, 20250Comments
